{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:59:12Z","timestamp":1785139152730,"version":"3.55.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-026-10661-z","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:30:23Z","timestamp":1784860223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A sex-specific perspective on coronary microvascular dysfunction in HFpEF: from vascular to myocardial disease"],"prefix":"10.1007","volume":"31","author":[{"given":"Anne-Sophie","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Marc","family":"Jolicoeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyne","family":"B\u00e9rub\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Forcillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Pelletier-Galarneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Bouabdallaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"11","key":"10661_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","volume":"124","author":"MA Pfeffer","year":"2019","unstructured":"Pfeffer MA, Shah AM, Borlaug BA (2019) Heart failure with preserved ejection fraction in perspective. Circ Res 124(11):1598\u20131617","journal-title":"Circ Res"},{"key":"10661_CR2","unstructured":"Meyer PB, A. L (2020) Sex differences in heart failure with preserved ejection fraction therapy: potential mechanisms and clinical implications. EMJ Cardiol 8(1):82\u201391"},{"issue":"18","key":"10661_CR3","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","volume":"81","author":"BA Borlaug","year":"2023","unstructured":"Borlaug BA et al (2023) Heart failure with preserved ejection fraction: JACC scientific statement. J Am Coll Cardiol 81(18):1810\u20131834","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10661_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","volume":"62","author":"WJ Paulus","year":"2013","unstructured":"Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62(4):263\u2013271","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10661_CR5","doi-asserted-by":"publisher","first-page":"e002562","DOI":"10.1161\/CIRCHEARTFAILURE.115.002562","volume":"9","author":"K Srivaratharajah","year":"2016","unstructured":"Srivaratharajah K et al (2016) Reduced myocardial flow in heart failure patients with preserved ejection fraction. Circ Heart Fail 9(7):e002562","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10661_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/HCO.0000000000001082","volume":"38","author":"A Sinha","year":"2023","unstructured":"Sinha A, Rahman H, Perera D (2023) Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links? Curr Opin Cardiol 38(6):521\u2013526","journal-title":"Curr Opin Cardiol"},{"issue":"12 Pt 2","key":"10661_CR7","doi-asserted-by":"publisher","first-page":"102345","DOI":"10.1016\/j.jacadv.2025.102345","volume":"4","author":"A Tzoumas","year":"2025","unstructured":"Tzoumas A et al (2025) The role of coronary microvascular dysfunction in heart failure with preserved ejection fraction. JACC Adv 4(12 Pt 2):102345","journal-title":"JACC Adv"},{"issue":"4","key":"10661_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"27","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt B et al (2021) Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail 27(4):387\u2013413","journal-title":"J Card Fail"},{"issue":"21","key":"10661_CR9","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","volume":"72","author":"VR Taqueti","year":"2018","unstructured":"Taqueti VR, Di Carli MF (2018) Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC State-of-the-art review. J Am Coll Cardiol 72(21):2625\u20132641","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10661_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1161\/CIRCULATIONAHA.114.009716","volume":"131","author":"VR Taqueti","year":"2015","unstructured":"Taqueti VR et al (2015) Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation 131(6):528\u2013535","journal-title":"Circulation"},{"issue":"10","key":"10661_CR11","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","volume":"39","author":"VR Taqueti","year":"2018","unstructured":"Taqueti VR et al (2018) Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J 39(10):840\u2013849","journal-title":"Eur Heart J"},{"issue":"6","key":"10661_CR12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/CIRCULATIONAHA.116.023266","volume":"135","author":"VR Taqueti","year":"2017","unstructured":"Taqueti VR et al (2017) Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease. Circulation 135(6):566\u2013577","journal-title":"Circulation"},{"issue":"6","key":"10661_CR13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","volume":"131","author":"SF Mohammed","year":"2015","unstructured":"Mohammed SF et al (2015) Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Circulation 131(6):550\u2013559","journal-title":"Circulation"},{"issue":"16","key":"10661_CR14","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jacc.2025.06.055","volume":"86","author":"M Packer","year":"2025","unstructured":"Packer M (2025) The adipokine hypothesis of heart failure with a preserved ejection fraction: a novel framework to explain pathogenesis and guide treatment. J Am Coll Cardiol 86(16):1269\u20131373","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10661_CR15","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL (2016) Sex differences in immune responses. Nat Rev Immunol 16(10):626\u2013638","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10661_CR16","doi-asserted-by":"publisher","first-page":"e0183874","DOI":"10.1371\/journal.pone.0183874","volume":"12","author":"K InanlooRahatloo","year":"2017","unstructured":"InanlooRahatloo K et al (2017) Sex-based differences in myocardial gene expression in recently deceased organ donors with no prior cardiovascular disease. PLoS ONE 12(8):e0183874","journal-title":"PLoS ONE"},{"issue":"1","key":"10661_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41824-025-00278-0","volume":"10","author":"V Sunder","year":"2026","unstructured":"Sunder V et al (2026) Characteristics associated with abnormal dynamic flow in patients with severe obesity undergoing PET myocardial perfusion imaging. EJNMMI Rep 10(1):2","journal-title":"EJNMMI Rep"},{"key":"10661_CR18","doi-asserted-by":"publisher","first-page":"979708","DOI":"10.3389\/fgwh.2022.979708","volume":"3","author":"S Kottilil","year":"2022","unstructured":"Kottilil S, Mathur P (2022) The influence of inflammation on cardiovascular disease in women. Front Glob Womens Health 3:979708","journal-title":"Front Glob Womens Health"},{"issue":"4","key":"10661_CR19","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/CIRCRESAHA.121.319902","volume":"130","author":"H Ji","year":"2022","unstructured":"Ji H et al (2022) Sex differences in myocardial and vascular aging. Circ Res 130(4):566\u2013577","journal-title":"Circ Res"},{"issue":"8","key":"10661_CR20","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/j.numecd.2024.04.002","volume":"34","author":"H Midtbo","year":"2024","unstructured":"Midtbo H et al (2024) Influence of cardiorespiratory fitness on obesity-associated inflammation in women and men: the FATCOR study. Nutr Metab Cardiovasc Dis 34(8):1942\u20131949","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"11","key":"10661_CR21","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","volume":"75","author":"SP Murphy","year":"2020","unstructured":"Murphy SP et al (2020) Inflammation in heart failure: JACC State-of-the-art review. J Am Coll Cardiol 75(11):1324\u20131340","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10661_CR22","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1093\/cvr\/cvac133","volume":"118","author":"NR Pugliese","year":"2023","unstructured":"Pugliese NR et al (2023) Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions. Cardiovasc Res 118(18):3536\u20133555","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10661_CR23","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/cvr\/cvaa023","volume":"116","author":"PG Camici","year":"2020","unstructured":"Camici PG et al (2020) Coronary microvascular dysfunction in hypertrophy and heart failure. Cardiovasc Res 116(4):806\u2013816","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10661_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","volume":"4","author":"D Westermann","year":"2011","unstructured":"Westermann D et al (2011) Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 4(1):44\u201352","journal-title":"Circ Heart Fail"},{"issue":"1 Pt 2","key":"10661_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1161\/01.HYP.33.1.323","volume":"33","author":"PE Gallagher","year":"1999","unstructured":"Gallagher PE et al (1999) Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension 33(1 Pt 2):323\u2013328","journal-title":"Hypertension"},{"key":"10661_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fendo.2019.00442","volume":"10","author":"AA Sickinghe","year":"2019","unstructured":"Sickinghe AA et al (2019) Estrogen contributions to microvascular dysfunction evolving to heart failure with preserved ejection fraction. Front Endocrinol (Lausanne) 10:442","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10661_CR27","doi-asserted-by":"publisher","first-page":"e002482","DOI":"10.1161\/JAHA.115.002482","volume":"5","author":"A Iorga","year":"2016","unstructured":"Iorga A et al (2016) Rescue of pressure overload-induced heart failure by estrogen therapy. J Am Heart Assoc 5(1):e002482","journal-title":"J Am Heart Assoc"},{"key":"10661_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mce.2016.06.018","volume":"434","author":"A Pedram","year":"2016","unstructured":"Pedram A et al (2016) Estrogen receptor beta signals to inhibition of cardiac fibrosis. Mol Cell Endocrinol 434:57\u201368","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"10661_CR29","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/ejhf.2146","volume":"23","author":"E Wolsk","year":"2021","unstructured":"Wolsk E et al (2021) Determinants and consequences of heart rate and stroke volume response to exercise in patients with heart failure and preserved ejection fraction. Eur J Heart Fail 23(5):754\u2013764","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10661_CR30","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/ejhf.2010","volume":"23","author":"A Ahmad","year":"2021","unstructured":"Ahmad A et al (2021) Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction. Eur J Heart Fail 23(5):765\u2013772","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10661_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jchf.2019.01.004","volume":"7","author":"AL Beale","year":"2019","unstructured":"Beale AL et al (2019) Sex differences in heart failure with preserved ejection fraction pathophysiology: a detailed invasive hemodynamic and echocardiographic analysis. JACC Heart Fail 7(3):239\u2013249","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10661_CR32","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jcmg.2016.02.003","volume":"9","author":"MB Patel","year":"2016","unstructured":"Patel MB et al (2016) Imaging microvascular dysfunction and mechanisms for female-male differences in CAD. JACC Cardiovasc Imaging 9(4):465\u2013482","journal-title":"JACC Cardiovasc Imaging"},{"key":"10661_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.amjcard.2023.07.031","volume":"205","author":"R Crosier","year":"2023","unstructured":"Crosier R et al (2023) Sex differences in systemic and coronary arterial hemodynamics in heart failure with preserved ejection fraction. Am J Cardiol 205:87\u201393","journal-title":"Am J Cardiol"},{"issue":"10","key":"10661_CR34","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jacc.2010.09.067","volume":"57","author":"CY Shim","year":"2011","unstructured":"Shim CY et al (2011) Sex differences in central hemodynamics and their relationship to left ventricular diastolic function. J Am Coll Cardiol 57(10):1226\u20131233","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10661_CR35","doi-asserted-by":"publisher","first-page":"e0156467","DOI":"10.1371\/journal.pone.0156467","volume":"11","author":"C Chen","year":"2016","unstructured":"Chen C et al (2016) Age, gender and load-related influences on left ventricular geometric remodeling, systolic mid-wall function, and NT-ProBNP in asymptomatic Asian population. PLoS ONE 11(6):e0156467","journal-title":"PLoS ONE"},{"issue":"3","key":"10661_CR36","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jcmg.2019.06.014","volume":"13","author":"L Tastet","year":"2020","unstructured":"Tastet L et al (2020) Sex-related differences in the extent of myocardial fibrosis in patients with aortic valve stenosis. JACC Cardiovasc Imaging 13(3):699\u2013711","journal-title":"JACC Cardiovasc Imaging"},{"issue":"15","key":"10661_CR37","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1161\/CIRCULATIONAHA.105.541078","volume":"112","author":"MM Redfield","year":"2005","unstructured":"Redfield MM et al (2005) Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 112(15):2254\u20132262","journal-title":"Circulation"},{"issue":"5","key":"10661_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ajog.2019.04.023","volume":"221","author":"A Ambikairajah","year":"2019","unstructured":"Ambikairajah A et al (2019) Fat mass changes during menopause: a metaanalysis. Am J Obstet Gynecol 221(5):393-409 e50","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10661_CR39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/0735-1097(94)90305-0","volume":"24","author":"DS Celermajer","year":"1994","unstructured":"Celermajer DS et al (1994) Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24(2):471\u2013476","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10661_CR40","doi-asserted-by":"publisher","first-page":"e003497","DOI":"10.1161\/CIRCOUTCOMES.116.003497","volume":"10","author":"P Wu","year":"2017","unstructured":"Wu P et al (2017) Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 10(2):e003497","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"12","key":"10661_CR41","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.2337\/diacare.21.12.2111","volume":"21","author":"E Anastasiou","year":"1998","unstructured":"Anastasiou E et al (1998) Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 21(12):2111\u20132115","journal-title":"Diabetes Care"},{"issue":"12","key":"10661_CR42","doi-asserted-by":"publisher","first-page":"e006539","DOI":"10.1161\/CIRCHEARTFAILURE.119.006539","volume":"12","author":"P Dewan","year":"2019","unstructured":"Dewan P et al (2019) Sex-related differences in heart failure with preserved ejection fraction. Circ Heart Fail 12(12):e006539","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10661_CR43","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1161\/ATVBAHA.107.158634","volume":"28","author":"C Vitale","year":"2008","unstructured":"Vitale C et al (2008) Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol 28(2):348\u2013352","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10661_CR44","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jchf.2019.01.003","volume":"7","author":"M Merrill","year":"2019","unstructured":"Merrill M et al (2019) Sex differences in outcomes and responses to spironolactone in heart failure with preserved ejection fraction: a secondary analysis of TOPCAT trial. JACC Heart Fail 7(3):228\u2013238","journal-title":"JACC Heart Fail"},{"issue":"11","key":"10661_CR45","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1161\/HYPERTENSIONAHA.124.22980","volume":"81","author":"WJ Yeo","year":"2024","unstructured":"Yeo WJ et al (2024) Sex differences in hypertension and its management throughout life. Hypertension 81(11):2263\u20132274","journal-title":"Hypertension"},{"issue":"10","key":"10661_CR46","first-page":"1857","volume":"41","author":"S Virani","year":"2025","unstructured":"Virani S et al (2025) Canadian Cardiovascular Society\/Canadian Heart Failure Society 2025 guideline update for pharmacologic management of heart failure with nonreduced ejection fraction (LVEF > 40%). Can J Cardiol 41(10):1857\u20131874","journal-title":"Can J Cardiol"},{"key":"10661_CR47","doi-asserted-by":"publisher","first-page":"1523727","DOI":"10.3389\/fphar.2025.1523727","volume":"16","author":"S Chen","year":"2025","unstructured":"Chen S et al (2025) Effect of sodium-glucose Co-transporter 2 inhibitors on coronary microcirculation. Front Pharmacol 16:1523727","journal-title":"Front Pharmacol"},{"issue":"1","key":"10661_CR48","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2337\/db14-0670","volume":"64","author":"R Garg","year":"2015","unstructured":"Garg R et al (2015) Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes. Diabetes 64(1):236\u2013242","journal-title":"Diabetes"},{"issue":"5","key":"10661_CR49","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2410027","volume":"392","author":"M Packer","year":"2025","unstructured":"Packer M et al (2025) Tirzepatide for heart failure with preserved ejection fraction and obesity. N Engl J Med 392(5):427\u2013437","journal-title":"N Engl J Med"},{"issue":"15","key":"10661_CR50","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","volume":"390","author":"MN Kosiborod","year":"2024","unstructured":"Kosiborod MN et al (2024) Semaglutide in patients with obesity-related heart failure and type 2 diabetes. N Engl J Med 390(15):1394\u20131407","journal-title":"N Engl J Med"},{"issue":"10489","key":"10661_CR51","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/S0140-6736(25)00509-4","volume":"405","author":"MP Bonaca","year":"2025","unstructured":"Bonaca MP et al (2025) Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial. Lancet 405(10489):1580\u20131593","journal-title":"Lancet"},{"issue":"3","key":"10661_CR52","doi-asserted-by":"publisher","first-page":"e241545","DOI":"10.1001\/jamanetworkopen.2024.1545","volume":"7","author":"P Caruso","year":"2024","unstructured":"Caruso P et al (2024) Liraglutide for lower limb perfusion in people with type 2 diabetes and peripheral artery disease: the STARDUST randomized clinical trial. JAMA Netw Open 7(3):e241545","journal-title":"JAMA Netw Open"},{"issue":"37","key":"10661_CR53","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1093\/eurheartj\/ehaa503","volume":"41","author":"V Kunadian","year":"2020","unstructured":"Kunadian V et al (2020) An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & microcirculation endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J 41(37):3504\u20133520","journal-title":"Eur Heart J"},{"issue":"3","key":"10661_CR54","doi-asserted-by":"publisher","first-page":"e12430","DOI":"10.1111\/micc.12430","volume":"26","author":"HE Suhrs","year":"2019","unstructured":"Suhrs HE, Michelsen MM, Prescott E (2019) Treatment strategies in coronary microvascular dysfunction: a systematic review of interventional studies. Microcirculation 26(3):e12430","journal-title":"Microcirculation"},{"key":"10661_CR55","doi-asserted-by":"publisher","first-page":"580419","DOI":"10.3389\/fcvm.2020.580419","volume":"7","author":"J Yong","year":"2020","unstructured":"Yong J et al (2020) Effects of oral drugs on coronary microvascular function in patients without significant stenosis of epicardial coronary arteries: a systematic review and meta-analysis of coronary flow reserve. Front Cardiovasc Med 7:580419","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"10661_CR56","first-page":"102633","volume":"4","author":"O Toleva","year":"2025","unstructured":"Toleva O et al (2025) Current evidence-based treatment of angina with nonobstructive coronary arteries (ANOCA). J Soc Cardiovasc Angiogr Interv 4(7):102633","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"10661_CR57","doi-asserted-by":"crossref","unstructured":"Nogami K, Borlaug BA, Harada T, Kalhor P, Manzato M, Raphael CE, Gulati R, Kakuta T, Lerman LO, Lerman A. Higher Prevalence of Coronary Microvascular Dysfunction in Patients With HFpEF Without Obesity. JACC Heart Fail. 2026 Jun;14(6):102894. doi: 10.1016\/j.jchf.2025.102894. Epub 2026 Jan 9. PMID: 41511429.","DOI":"10.1016\/j.jchf.2025.102894"},{"issue":"3","key":"10661_CR58","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jchf.2019.09.009","volume":"8","author":"JB Cohen","year":"2020","unstructured":"Cohen JB et al (2020) Clinical phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone. JACC Heart Fail 8(3):172\u2013184","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10661_CR59","first-page":"415","volume":"40","author":"K Kagami","year":"2022","unstructured":"Kagami K et al (2022) Key phenotypes of heart failure with preserved ejection fraction: pathophysiologic mechanisms and potential treatment strategies. Cardiol Clin 40(4):415\u2013429","journal-title":"Cardiol Clin"},{"issue":"8","key":"10661_CR60","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/eurheartj\/ehp013","volume":"30","author":"TH Schindler","year":"2009","unstructured":"Schindler TH et al (2009) Effect of hormone replacement therapy on vasomotor function of the coronary microcirculation in post-menopausal women with medically treated cardiovascular risk factors. Eur Heart J 30(8):978\u2013986","journal-title":"Eur Heart J"},{"issue":"4","key":"10661_CR61","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/hc0402.102860","volume":"105","author":"R Campisi","year":"2002","unstructured":"Campisi R et al (2002) Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration. Circulation 105(4):425\u2013430","journal-title":"Circulation"},{"issue":"6","key":"10661_CR62","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/01.CIR.89.6.2545","volume":"89","author":"DM Gilligan","year":"1994","unstructured":"Gilligan DM, Quyyumi AA, Cannon RO 3rd (1994) Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 89(6):2545\u20132551","journal-title":"Circulation"},{"issue":"12","key":"10661_CR63","doi-asserted-by":"publisher","first-page":"936","DOI":"10.7326\/0003-4819-121-12-199412150-00005","volume":"121","author":"EH Lieberman","year":"1994","unstructured":"Lieberman EH et al (1994) Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 121(12):936\u2013941","journal-title":"Ann Intern Med"},{"issue":"16","key":"10661_CR64","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1161\/01.CIR.98.16.1631","volume":"98","author":"SF Yim","year":"1998","unstructured":"Yim SF et al (1998) Prospective randomized study of the effect of \u201cadd-back\u201d hormone replacement on vascular function during treatment with gonadotropin-releasing hormone agonists. Circulation 98(16):1631\u20131635","journal-title":"Circulation"},{"issue":"4","key":"10661_CR65","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1210\/jcem.85.4.6530","volume":"85","author":"NG Majmudar","year":"2000","unstructured":"Majmudar NG, Robson SC, Ford GA (2000) Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J Clin Endocrinol Metab 85(4):1577\u20131583","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10661_CR66","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jacc.2019.12.049","volume":"75","author":"AR Sabbatini","year":"2020","unstructured":"Sabbatini AR, Kararigas G (2020) Menopause-related estrogen decrease and the pathogenesis of HFpEF: JACC review topic of the week. J Am Coll Cardiol 75(9):1074\u20131082","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10661_CR67","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jama.288.1.49","volume":"288","author":"D Grady","year":"2002","unstructured":"Grady D et al (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen\/progestin replacement study follow-up (HERS II). JAMA 288(1):49\u201357","journal-title":"JAMA"},{"issue":"7","key":"10661_CR68","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/jama.280.7.605","volume":"280","author":"S Hulley","year":"1998","unstructured":"Hulley S et al (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group. JAMA 280(7):605\u201313","journal-title":"JAMA"},{"issue":"1","key":"10661_CR69","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13293-017-0152-8","volume":"8","author":"A Iorga","year":"2017","unstructured":"Iorga A et al (2017) The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ 8(1):33","journal-title":"Biol Sex Differ"},{"issue":"13","key":"10661_CR70","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","volume":"297","author":"JE Rossouw","year":"2007","unstructured":"Rossouw JE et al (2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297(13):1465\u20131477","journal-title":"JAMA"},{"issue":"8","key":"10661_CR71","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1161\/ATVBAHA.107.145383","volume":"27","author":"A Sherwood","year":"2007","unstructured":"Sherwood A et al (2007) Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. Arterioscler Thromb Vasc Biol 27(8):1782\u20131787","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10661_CR72","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jchf.2018.06.008","volume":"6","author":"KS Parikh","year":"2018","unstructured":"Parikh KS et al (2018) Heart failure with preserved ejection fraction expert panel report: current controversies and implications for clinical trials. JACC Heart Fail 6(8):619\u2013632","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10661_CR73","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cardfail.2023.10.024","volume":"30","author":"M Petrie","year":"2024","unstructured":"Petrie M et al (2024) HERMES: effects Of Ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation. J Cardiac Failure 30(1):126","journal-title":"J Cardiac Failure"},{"issue":"10","key":"10661_CR74","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamacardio.2023.2566","volume":"8","author":"H Ullrich","year":"2023","unstructured":"Ullrich H et al (2023) Coronary venous pressure and microvascular hemodynamics in patients with microvascular angina: a randomized clinical trial. JAMA Cardiol 8(10):979\u2013983","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10661_CR75","doi-asserted-by":"publisher","first-page":"e013481","DOI":"10.1161\/CIRCINTERVENTIONS.123.013481","volume":"17","author":"M Tebaldi","year":"2024","unstructured":"Tebaldi M et al (2024) Coronary sinus narrowing improves coronary microcirculation function in patients with refractory angina: a multicenter prospective INROAD study. Circ Cardiovasc Interv 17(1):e013481","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"10661_CR76","doi-asserted-by":"publisher","first-page":"e010802","DOI":"10.1161\/CIRCINTERVENTIONS.121.010802","volume":"15","author":"TD Henry","year":"2022","unstructured":"Henry TD et al (2022) Autologous CD34+ stem cell therapy increases coronary flow reserve and reduces angina in patients with coronary microvascular dysfunction. Circ Cardiovasc Interv 15(2):e010802","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10661-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-026-10661-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10661-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:01:51Z","timestamp":1785135711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-026-10661-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10661"],"URL":"https:\/\/doi.org\/10.1007\/s10741-026-10661-z","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"12 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No conflicts of interest.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"87"}}